デフォルト表紙
市場調査レポート
商品コード
1472029

ドラッグデリバリー技術市場:2024-2034年

Drug Delivery Technologies Market Report 2024-2034

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 328 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=204.52円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

ドラッグデリバリー技術市場:2024-2034年
出版日: 2024年04月23日
発行: Visiongain Reports Ltd.
ページ情報: 英文 328 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のドラッグデリバリー技術の市場規模は、2034年にかけてCAGR 5.5%で成長すると予測されています。

ドラッグデリバリー技術の成長は、慢性疾患の蔓延、生物製剤市場の急成長、R&D投資の増加、技術革新、新規製品の導入など、複数の主要な要因によって推進されています。また、製薬・バイオ医薬品企業は、多様な治療用途や革新的なドラッグデリバリープラットフォームに合わせた新しい分子体の育成を目指したR&Dに戦略的に資源を投入しています。これらの企業は、優れた品質の画期的な製品を確実にマーケットプレースに送り出すため、R&Dへの多額の投資に取り組んでいます。特に、バイオ医薬品企業によるR&Dへの資金配分は、時間の経過とともに大幅に増加しています。しかし、針刺し損傷リスクの高まりや価格圧力の上昇など、当面の市場成長に対する潜在的な制約を認識することが不可欠です。

当レポートでは、世界のドラッグデリバリー技術の市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場牽引要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 ドラッグデリバリー技術市場の分析:投与経路別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 埋め込みドラッグデリバリー
  • 注射ドラッグデリバリー
  • 鼻腔内ドラッグデリバリー
  • 眼科ドラッグデリバリー
  • 経口ドラッグデリバリー
  • 経肺ドラッグデリバリー
  • 局所ドラッグデリバリー
  • 経粘膜ドラッグデリバリー
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第5章 ドラッグデリバリー技術市場の分析:用途別のドラッグデリバリー技術市場分析

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 心臓血管
  • 糖尿病
  • 感染症
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第6章 ドラッグデリバリー技術市場の分析:エンドユーザー別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 外来手術センター
  • 病院
  • 在宅ケア
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第7章 ドラッグデリバリー技術市場の分析:地域別

  • 主要調査結果
  • 市場規模の推移・予測

第8章 北米のドラッグデリバリー技術市場の分析

第9章 欧州のドラッグデリバリー技術市場の分析

第10章 アジア太平洋のドラッグデリバリー技術市場の分析

第11章 ラテンアメリカのドラッグデリバリー技術市場の分析

第12章 中東・アフリカのドラッグデリバリー技術市場の分析

第13章 企業プロファイル

  • Johnson &Johnson Services, Inc.
  • Novartis AG
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • GSK plc
  • Merck &Co., Inc.
  • Sanofi
  • Amgen Inc.
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Boehringer Ingelheim
  • AstraZeneca plc
  • Eli Lilly and Company
  • Teva Pharmaceuticals Industries Ltd.
  • Bristol-Myers Squibb
  • Gerresheimer AG
  • Boston Scientific Corporation

第14章 総論・提言

  • Visiongainからの総論
  • 参入企業への推奨事項
図表

List of Tables

  • Table 1 Drug Delivery Technologies Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)
  • Table 2 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 7 Implantable Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 8 Injectable Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 9 Nasal Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 10 Ocular Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 11 Oral Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 12 Pulmonary Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 13 Topical Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 14 Transmucosal Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 15 Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 16 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 17 Cardiovascular Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 18 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 19 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 20 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 21 Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 22 Ambulatory Surgical Centres Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 23 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 24 Home Care Settings Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 25 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 26 Drug Delivery Technologies Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 27 North America Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 28 North America Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 29 North America Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 30 North America Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 31 U.S. Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 32 Canada Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 33 Europe Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 34 Europe Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 35 Europe Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 36 Europe Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 37 Germany Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 38 UK Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 39 France Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 40 Italy Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 41 Spain Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 42 Russia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 43 Rest of Europe Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 44 Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 45 Asia Pacific Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 46 Asia Pacific Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 47 Asia Pacific Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 48 Japan Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 49 China Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 50 India Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 51 Australia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 52 South Korea Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 53 South-East Asia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 54 Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 55 Latin America Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 56 Latin America Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 57 Latin America Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 58 Latin America Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 59 Brazil Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 60 Mexico Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 61 Rest of Latin America Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 62 MEA Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 63 MEA Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 64 MEA Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 65 MEA Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 66 GCC Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 67 South Africa Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 68 Rest of MEA Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)
  • Table 69 Johnson & Johnson Services, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 70 Johnson & Johnson Services, Inc.: Product Benchmarking
  • Table 71 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 72 Novartis AG: Product Benchmarking
  • Table 73 Novartis AG: Strategic Outlook
  • Table 74 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 75 F. Hoffmann-La Roche Ltd: Product Benchmarking
  • Table 76 F. Hoffmann-La Roche Ltd: Strategic Outlook
  • Table 77 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 78 Pfizer Inc.: Product Benchmarking
  • Table 79 Pfizer Inc.: Strategic Outlook
  • Table 80 Bayer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 81 Bayer AG: Product Benchmarking
  • Table 82 Bayer AG: Strategic Outlook
  • Table 83 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 84 Becton, Dickinson and Company: Product Benchmarking
  • Table 85 Becton, Dickinson and Company: Strategic Outlook
  • Table 86 GSK plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 87 GSK plc: Product Benchmarking
  • Table 88 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 89 Merck & Co., Inc.: Product Benchmarking
  • Table 90 Merck & Co., Inc.: Strategic Outlook
  • Table 91 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 92 Sanofi: Product Benchmarking
  • Table 93 Sanofi: Strategic Outlook
  • Table 94 Amgen Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 Amgen Inc.: Product Benchmarking
  • Table 96 Amgen Inc.: Strategic Outlook
  • Table 97 AbbVie Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 AbbVie Inc.: Product Benchmarking
  • Table 99 AbbVie Inc.: Strategic Outlook
  • Table 100 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 Gilead Sciences, Inc.: Product Benchmarking
  • Table 102 Gilead Sciences, Inc.: Strategic Outlook
  • Table 103 Boehringer Ingelheim: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Boehringer Ingelheim: Product Benchmarking
  • Table 105 AstraZeneca plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 106 AstraZeneca plc: Product Benchmarking
  • Table 107 AstraZeneca plc: Strategic Outlook
  • Table 108 Eli Lilly and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 109 Eli Lilly and Company: Product Benchmarking
  • Table 110 Eli Lilly and Company: Strategic Outlook
  • Table 111 Teva Pharmaceuticals Industries Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 112 Teva Pharmaceuticals Industries Ltd.: Product Benchmarking
  • Table 113 Teva Pharmaceuticals Industries Ltd.: Strategic Outlook
  • Table 114 Bristol-Myers Squibb: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 Bristol-Myers Squibb: Product Benchmarking
  • Table 116 Gerresheimer AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 117 Gerresheimer AG: Product Benchmarking
  • Table 118 Gerresheimer AG: Strategic Outlook
  • Table 119 Boston Scientific Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 120 Boston Scientific Corporation: Product Benchmarking
  • Table 121 Boston Scientific Corporation: Strategic Outlook

List of Figures

  • Figure 1 Drug Delivery Technologies Market Segmentation
  • Figure 2 Drug Delivery Technologies Market by Route of Administration: Market Attractiveness Index
  • Figure 3 Drug Delivery Technologies Market by Application: Market Attractiveness Index
  • Figure 4 Drug Delivery Technologies Market by End-users: Market Attractiveness Index
  • Figure 5 Drug Delivery Technologies Market Attractiveness Index by Region
  • Figure 6 Drug Delivery Technologies Market: Market Dynamics
  • Figure 7 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Billion, AGR %): "V" Shaped Recovery
  • Figure 8 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Billion, AGR %): "U" Shaped Recovery
  • Figure 9 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Billion, AGR %): "W" Shaped Recovery
  • Figure 10 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Billion, AGR %): "L" Shaped Recovery
  • Figure 11 Drug Delivery Technologies Market: Porter's Five Forces Analysis
  • Figure 12 Drug Delivery Technologies Market: PEST Analysis
  • Figure 13 Drug Delivery Technologies Market Attractiveness Index by Route of Administration
  • Figure 14 Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
  • Figure 15 Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024, 2029, 2034 (%)
  • Figure 16 Implantable Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 17 Implantable Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 18 Injectable Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 19 Injectable Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 20 Nasal Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 21 Nasal Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 22 Ocular Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 23 Ocular Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 24 Oral Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 25 Oral Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 26 Pulmonary Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 27 Pulmonary Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 28 Topical Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 29 Topical Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 30 Transmucosal Drug Delivery Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 31 Transmucosal Drug Delivery Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 32 Drug Delivery Technologies Market Attractiveness Index by Route of Administration
  • Figure 33 Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 34 Drug Delivery Technologies Market Share Forecast by Application, 2024, 2029, 2034 (%)
  • Figure 35 Cancer Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 36 Cancer Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 37 Cardiovascular Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 38 Cardiovascular Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 39 Diabetes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 40 Diabetes Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 41 Infectious Diseases Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 42 Infectious Diseases Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 43 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 44 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Drug Delivery Technologies Market Attractiveness Index by End-users
  • Figure 46 Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 47 Drug Delivery Technologies Market Share Forecast by End-users, 2024, 2029, 2034 (%)
  • Figure 48 Ambulatory Surgical Centres Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 49 Ambulatory Surgical Centres Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 50 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 51 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 52 Home Care Settings Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 53 Home Care Settings Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 54 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
  • Figure 55 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 56 Drug Delivery Technologies Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
  • Figure 57 Drug Delivery Technologies Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 58 Drug Delivery Technologies Market by Region, 2024-2034 (US$ Bn, AGR %)
  • Figure 59 North America Drug Delivery Technologies Market Attractiveness Index
  • Figure 60 North America Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 61 North America Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 62 North America Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 63 North America Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
  • Figure 64 North America Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
  • Figure 65 North America Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 66 North America Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 67 North America Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 68 North America Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 69 U.S. Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 70 Canada Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 71 Europe Drug Delivery Technologies Market Attractiveness Index
  • Figure 72 Europe Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 73 Europe Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 74 Europe Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 75 Europe Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
  • Figure 76 Europe Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
  • Figure 77 Europe Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 78 Europe Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 79 Europe Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 80 Europe Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 81 Germany Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 82 UK Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 83 France Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 84 Italy Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 85 Spain Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 86 Russia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 87 Rest of Europe Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 88 Asia Pacific Drug Delivery Technologies Market Attractiveness Index
  • Figure 89 Asia Pacific Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 90 Asia Pacific Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 91 Asia Pacific Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 92 Asia Pacific Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
  • Figure 93 Asia Pacific Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
  • Figure 94 Asia Pacific Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 95 Asia Pacific Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 96 Asia Pacific Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 97 Asia Pacific Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 98 Japan Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 99 China Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 100 India Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 101 Australia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 102 South Korea Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 103 South-East Asia Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 104 Rest of Asia Pacific Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 105 Latin America Drug Delivery Technologies Market Attractiveness Index
  • Figure 106 Latin America Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 107 Latin America Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 108 Latin America Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 109 Latin America Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
  • Figure 110 Latin America Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
  • Figure 111 Latin America Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 112 Latin America Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 113 Latin America Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 114 Latin America Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 115 Brazil Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 116 Mexico Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 117 Rest of Latin America Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 118 MEA Drug Delivery Technologies Market Attractiveness Index
  • Figure 119 MEA Drug Delivery Technologies Market by Region, 2024, 2029 & 2034 (US$ Billion)
  • Figure 120 MEA Drug Delivery Technologies Market Forecast by Country, 2024-2034 (US$ Billion, AGR %)
  • Figure 121 MEA Drug Delivery Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 122 MEA Drug Delivery Technologies Market Forecast by Route of Administration, 2024-2034 (US$ Billion, AGR %)
  • Figure 123 MEA Drug Delivery Technologies Market Share Forecast by Route of Administration, 2024 & 2034 (%)
  • Figure 124 MEA Drug Delivery Technologies Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)
  • Figure 125 MEA Drug Delivery Technologies Market Share Forecast by Application, 2024 & 2034 (%)
  • Figure 126 MEA Drug Delivery Technologies Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)
  • Figure 127 MEA Drug Delivery Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 128 GCC Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 129 South Africa Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 130 Rest of MEA Drug Delivery Technologies Market Forecast, 2024-2034 (US$ Billion, AGR %)
  • Figure 131 Johnson & Johnson Services, Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 132 Johnson & Johnson Services, Inc.: Regional Market Shares (%), 2023
  • Figure 133 Johnson & Johnson Services, Inc.: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 134 Novartis AG: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 135 Novartis AG: Regional Market Shares (%), 2023
  • Figure 136 Novartis AG: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 137 F. Hoffmann-La Roche Ltd: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 138 F. Hoffmann-La Roche Ltd: Regional Market Shares (%), 2023
  • Figure 139 F. Hoffmann-La Roche Ltd: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 140 Pfizer Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 141 Pfizer Inc.: Regional Market Shares (%), 2023
  • Figure 142 Pfizer Inc.: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 143 Bayer AG: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 144 Bayer AG: Regional Market Shares (%), 2022
  • Figure 145 Bayer AG: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 146 Becton, Dickinson and Company: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 147 Becton, Dickinson and Company: Regional Market Shares (%), 2023
  • Figure 148 Becton, Dickinson and Company: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 149 GSK plc: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 150 GSK plc: Regional Market Shares (%), 2023
  • Figure 151 GSK plc: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 152 Merck & Co., Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 153 Merck & Co., Inc.: Regional Market Shares (%), 2023
  • Figure 154 Merck & Co., Inc.: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 155 Sanofi: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 156 Sanofi: Regional Market Shares (%), 2023
  • Figure 157 Sanofi: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 158 Amgen Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 159 Amgen Inc.: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 160 Amgen Inc.: Regional Market Shares (%), 2023
  • Figure 161 AbbVie Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 162 AbbVie Inc.: Regional Market Shares (%), 2023
  • Figure 163 AbbVie Inc.: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 164 Gilead Sciences, Inc.: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 165 Gilead Sciences, Inc.: R&D, 2015-2023 (US$ Million, AGR%)
  • Figure 166 Boehringer Ingelheim: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 167 Boehringer Ingelheim: Regional Market Shares (%), 2022
  • Figure 168 AstraZeneca plc: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 169 AstraZeneca plc: Regional Market Shares (%), 2023
  • Figure 170 AstraZeneca plc: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 171 Eli Lilly and Company: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 172 Eli Lilly and Company: Regional Market Shares (%), 2023
  • Figure 173 Eli Lilly and Company: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 174 Teva Pharmaceuticals Industries Ltd.: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 175 Teva Pharmaceuticals Industries Ltd.: Regional Market Shares (%), 2023
  • Figure 176 Teva Pharmaceuticals Industries Ltd.: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 177 Bristol-Myers Squibb: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 178 Bristol-Myers Squibb: Regional Market Shares (%), 2023
  • Figure 179 Bristol-Myers Squibb: R&D, 2015-2022 (US$ Million, AGR%)
  • Figure 180 Gerresheimer AG: Net Revenue, 2015-2023 (US$ Million, AGR%)
  • Figure 181 Gerresheimer AG: Regional Market Shares (%), 2023
  • Figure 182 Boston Scientific Corporation: Net Revenue, 2015-2022 (US$ Million, AGR%)
  • Figure 183 Boston Scientific Corporation: Regional Market Shares (%), 2023
  • Figure 184 Boston Scientific Corporation: R&D, 2015-2022 (US$ Million, AGR%)
目次
Product Code: PHA1322

The global Drug Delivery Technologies market is projected to grow at a CAGR of 5.5% by 2034

The Drug Delivery Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

The expansion observed in the drug delivery technologies sector can be largely attributed to several key drivers. These include the escalating prevalence of chronic ailments, the burgeoning biologics market, heightened investments in research and development, technological breakthroughs, and the introduction of novel products. Additionally, pharmaceutical and biopharmaceutical enterprises are strategically directing resources towards research and development endeavours aimed at cultivating new molecular entities tailored for diverse therapeutic applications and innovative drug delivery platforms. These companies are committed to substantial investments in research and development endeavours to ensure the delivery of superior-quality and ground-breaking products to the marketplace. Notably, the allocation of funds towards research and development by biopharmaceutical entities has witnessed a significant uptick over time. However, it's imperative to acknowledge potential constraints to market growth in the foreseeable future, such as the heightened risk of needlestick injuries and escalating pricing pressures.

What Questions Should You Ask before Buying a Market Research Report?

How is the drug delivery technologies market evolving?

What is driving and restraining the drug delivery technologies market?

How will each drug delivery technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each drug delivery technologies submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading drug delivery technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the drug delivery technologies projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of

drug delivery technologies projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the drug delivery technologies market?

Where is the drug delivery technologies market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the drug delivery technologies market today, and over the next 10 years:

Our 328-page report provides 121 tables, 184 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the drug delivery technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Route of Administration

Implantable Drug Delivery

Injectable Drug Delivery

Nasal Drug Delivery

Ocular Drug Delivery

Oral Drug Delivery

Pulmonary Drug Delivery

Topical Drug Delivery

Transmucosal Drug Delivery

Application

Cancer

Cardiovascular

Diabetes

Infectious Diseases

Others

End-users

Ambulatory Surgical Centres

Hospitals

Home Care Settings

Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Drug Delivery Technologies Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth

AbbVie Inc.

Amgen Inc.

AstraZeneca plc

Bayer AG

BD

Boehringer Ingelheim

Boston Scientific Corporation

Bristol-Myers Squibb

Eli Lilly and Company

F. Hoffmann-La Roche Ltd.

Gerresheimer AG

Gilead Sciences, Inc.

GSK plc

Johnson & Johnson Services, Inc.

Novartis AG

Merck & Co., Inc.

Pfizer Inc.

Sanofi

Teva Pharmaceuticals Industries Ltd.

Overall world revenue for Drug Delivery Technologies Market, 2024 to 2034 in terms of value the market will surpass US$1,700 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Drug Delivery Technologies Market, 2024 to 2034 report help you?

In summary, our 320+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Drug Delivery Technologies Market 2024 to 2034, with forecasts for route of administration, application, and end-users each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 21 key national markets - See forecasts for the Drug Delivery Technologies Market, 2024 to 2034 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 19 of the major companies involved in the Drug Delivery Technologies Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Drug Delivery Technologies Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Drug Delivery Technologies Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Rising Prevalence of Chronic Diseases
      • 3.2.1.2 Technological Advancements Driving Industry Growth
      • 3.2.1.3 Rising Focus on Patient-centric Care
      • 3.2.1.4 Integration of AI and Big Data
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Lack of Awareness and Infrastructure
      • 3.2.2.2 Risk of Needlestick Injuries
      • 3.2.2.3 Reimbursement Issues in Advanced Drug Delivery Technologies
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Self-administration and Home Care
      • 3.2.3.2 Digital Integration and Connectivity
      • 3.2.3.3 Expanding Applications in Biologics and Gene Therapies
      • 3.2.3.4 Sustainable and Eco-friendly Innovations in Drug Delivery Technologies
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Supplier Power
    • 3.4.2 Buyer Power
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Drug Delivery Technologies Market Analysis by Route of Administration

  • 4.1 Key Findings
  • 4.2 Route of Administration Segment: Market Attractiveness Index
  • 4.3 Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 4.4 Implantable Drug Delivery
    • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Injectable Drug Delivery
    • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Nasal Drug Delivery
    • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Ocular Drug Delivery
    • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Oral Drug Delivery
    • 4.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Pulmonary Drug Delivery
    • 4.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)
  • 4.10 Topical Drug Delivery
    • 4.10.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.10.2 Market Share by Region, 2024 & 2034 (%)
  • 4.11 Transmucosal Drug Delivery
    • 4.11.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 4.11.2 Market Share by Region, 2024 & 2034 (%)

5 Drug Delivery Technologies Market Analysis by Application

  • 5.1 Key Findings
  • 5.2 Application Segment: Market Attractiveness Index
  • 5.3 Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 5.4 Cancer
    • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Cardiovascular
    • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Diabetes
    • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)
  • 5.7 Infectious Diseases
    • 5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.7.2 Market Share by Region, 2024 & 2034 (%)
  • 5.8 Others
    • 5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 5.8.2 Market Share by Region, 2024 & 2034 (%)

6 Drug Delivery Technologies Market Analysis by End-users

  • 6.1 Key Findings
  • 6.2 End-users Segment: Market Attractiveness Index
  • 6.3 Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 6.4 Ambulatory Surgical Centres
    • 6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Hospitals
    • 6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Home Care Settings
    • 6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)
  • 6.7 Others
    • 6.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)
    • 6.7.2 Market Share by Region, 2024 & 2034 (%)

7 Drug Delivery Technologies Market Analysis by Region

  • 7.1 Key Findings
  • 7.2 Regional Market Size Estimation and Forecast

8 North America Drug Delivery Technologies Market Analysis

  • 8.1 Key Findings
  • 8.2 North America Drug Delivery Technologies Market Attractiveness Index
  • 8.3 North America Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 8.4 North America Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 8.5 North America Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 8.6 North America Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 8.7 North America Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 8.8 U.S. Drug Delivery Technologies Market Analysis
  • 8.9 Canada Drug Delivery Technologies Market Analysis

9 Europe Drug Delivery Technologies Market Analysis

  • 9.1 Key Findings
  • 9.2 Europe Drug Delivery Technologies Market Attractiveness Index
  • 9.3 Europe Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 9.4 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 9.5 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 9.6 Europe Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 9.7 Europe Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 9.8 Germany Drug Delivery Technologies Market Analysis
  • 9.9 UK Drug Delivery Technologies Market Analysis
  • 9.10 France Drug Delivery Technologies Market Analysis
  • 9.11 Italy Drug Delivery Technologies Market Analysis
  • 9.12 Spain Drug Delivery Technologies Market Analysis
  • 9.13 Russia Drug Delivery Technologies Market Analysis
  • 9.14 Rest of Europe Drug Delivery Technologies Market Analysis

10 Asia Pacific Drug Delivery Technologies Market Analysis

  • 10.1 Key Findings
  • 10.2 Asia Pacific Drug Delivery Technologies Market Attractiveness Index
  • 10.3 Asia Pacific Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 10.4 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 10.5 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 10.6 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 10.7 Asia Pacific Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 10.8 Japan Drug Delivery Technologies Market Analysis
  • 10.9 China Drug Delivery Technologies Market Analysis
  • 10.10 India Drug Delivery Technologies Market Analysis
  • 10.11 Australia Drug Delivery Technologies Market Analysis
  • 10.12 South Korea Drug Delivery Technologies Market Analysis
  • 10.13 South-East Asia Drug Delivery Technologies Market Analysis
  • 10.14 Rest of Asia Pacific Drug Delivery Technologies Market Analysis

11 Latin America Drug Delivery Technologies Market Analysis

  • 11.1 Key Findings
  • 11.2 Latin America Drug Delivery Technologies Market Attractiveness Index
  • 11.3 Latin America Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 11.4 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 11.5 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 11.6 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 11.7 Latin America Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 11.8 Brazil Drug Delivery Technologies Market Analysis
  • 11.9 Mexico Drug Delivery Technologies Market Analysis
  • 11.10 Rest of Latin America Drug Delivery Technologies Market Analysis

12 MEA Drug Delivery Technologies Market Analysis

  • 12.1 Key Findings
  • 12.2 MEA Drug Delivery Technologies Market Attractiveness Index
  • 12.3 MEA Drug Delivery Technologies Market by Country, 2024, 2029 & 2034 (US$ Billion)
  • 12.4 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Country
  • 12.5 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Route of Administration
  • 12.6 MEA Drug Delivery Technologies Market Size Estimation and Forecast by Application
  • 12.7 MEA Drug Delivery Technologies Market Size Estimation and Forecast by End-users
  • 12.8 GCC Drug Delivery Technologies Market Analysis
  • 12.9 South Africa Drug Delivery Technologies Market Analysis
  • 12.10 Rest of MEA Drug Delivery Technologies Market Analysis

13 Company Profiles

  • 13.1 Johnson & Johnson Services, Inc.
    • 13.1.1 Company Snapshot
    • 13.1.2 Company Overview
    • 13.1.3 Financial Analysis
      • 13.1.3.1 Net Revenue, 2015-2023
      • 13.1.3.2 Regional Market Shares, 2023
      • 13.1.3.3 R&D, 2015-2023
    • 13.1.4 Product Benchmarking
  • 13.2 Novartis AG
    • 13.2.1 Company Snapshot
    • 13.2.2 Company Overview
    • 13.2.3 Financial Analysis
      • 13.2.3.1 Net Revenue, 2015-2023
      • 13.2.3.2 Regional Market Shares, 2023
      • 13.2.3.3 R&D, 2015-2023
    • 13.2.4 Product Benchmarking
    • 13.2.5 Strategic Outlook
  • 13.3 F. Hoffmann-La Roche Ltd.
    • 13.3.1 Company Snapshot
    • 13.3.2 Company Overview
    • 13.3.3 Financial Analysis
      • 13.3.3.1 Net Revenue, 2015-2023
      • 13.3.3.2 Regional Market Shares, 2023
      • 13.3.3.3 R&D, 2015-2023
    • 13.3.4 Product Benchmarking
    • 13.3.5 Strategic Outlook
  • 13.4 Pfizer Inc.
    • 13.4.1 Company Snapshot
    • 13.4.2 Company Overview
    • 13.4.3 Financial Analysis
      • 13.4.3.1 Net Revenue, 2015-2023
      • 13.4.3.2 Regional Market Shares, 2023
      • 13.4.3.3 R&D, 2015-2023
    • 13.4.4 Product Benchmarking
    • 13.4.5 Strategic Outlook
  • 13.5 Bayer AG
    • 13.5.1 Company Snapshot
    • 13.5.2 Company Overview
    • 13.5.3 Financial Analysis
      • 13.5.3.1 Net Revenue, 2015-2022
      • 13.5.3.2 Regional Market Shares, 2022
      • 13.5.3.3 R&D, 2015-2022
    • 13.5.4 Product Benchmarking
    • 13.5.5 Strategic Outlook
  • 13.6 Becton, Dickinson and Company
    • 13.6.1 Company Snapshot
    • 13.6.2 Company Overview
    • 13.6.3 Financial Analysis
      • 13.6.3.1 Net Revenue, 2015-2023
      • 13.6.3.2 Regional Market Shares, 2023
      • 13.6.3.3 R&D, 2015-2023
    • 13.6.4 Product Benchmarking
    • 13.6.5 Strategic Outlook
  • 13.7 GSK plc
    • 13.7.1 Company Snapshot
    • 13.7.2 Company Overview
    • 13.7.3 Financial Analysis
      • 13.7.3.1 Net Revenue, 2015-2023
      • 13.7.3.2 Regional Market Shares, 2023
      • 13.7.3.3 R&D, 2015-2023
    • 13.7.4 Product Benchmarking
  • 13.8 Merck & Co., Inc.
    • 13.8.1 Company Snapshot
    • 13.8.2 Company Overview
    • 13.8.3 Financial Analysis
      • 13.8.3.1 Net Revenue, 2015-2023
      • 13.8.3.2 Regional Market Shares, 2023
      • 13.8.3.3 R&D, 2015-2023
    • 13.8.4 Product Benchmarking
    • 13.8.5 Strategic Outlook
  • 13.9 Sanofi
    • 13.9.1 Company Snapshot
    • 13.9.2 Company Overview
    • 13.9.3 Financial Analysis
      • 13.9.3.1 Net Revenue, 2015-2023
      • 13.9.3.2 Regional Market Shares, 2023
      • 13.9.3.3 R&D, 2015-2023
    • 13.9.4 Product Benchmarking
    • 13.9.5 Strategic Outlook
  • 13.10 Amgen Inc.
    • 13.10.1 Company Snapshot
    • 13.10.2 Company Overview
    • 13.10.3 Financial Analysis
      • 13.10.3.1 Net Revenue, 2015-2023
      • 13.10.3.2 R&D, 2015-2023
      • 13.10.3.3 Regional Market Shares, 2023
    • 13.10.4 Product Benchmarking
    • 13.10.5 Strategic Outlook
  • 13.11 AbbVie Inc.
    • 13.11.1 Company Snapshot
    • 13.11.2 Company Overview
    • 13.11.3 Financial Analysis
      • 13.11.3.1 Net Revenue, 2015-2023
      • 13.11.3.2 Regional Market Shares, 2023
      • 13.11.3.3 R&D, 2015-2023
    • 13.11.4 Product Benchmarking
    • 13.11.5 Strategic Outlook
  • 13.12 Gilead Sciences, Inc.
    • 13.12.1 Company Snapshot
    • 13.12.2 Company Overview
    • 13.12.3 Financial Analysis
      • 13.12.3.1 Net Revenue, 2015-2023
      • 13.12.3.2 R&D, 2015-2023
    • 13.12.4 Product Benchmarking
    • 13.12.5 Strategic Outlook
  • 13.13 Boehringer Ingelheim
    • 13.13.1 Company Snapshot
    • 13.13.2 Company Overview
    • 13.13.3 Financial Analysis
      • 13.13.3.1 Net Revenue, 2015-2022
      • 13.13.3.2 Regional Market Shares, 2022
    • 13.13.4 Product Benchmarking
  • 13.14 AstraZeneca plc
    • 13.14.1 Company Snapshot
    • 13.14.2 Company Overview
    • 13.14.3 Financial Analysis
      • 13.14.3.1 Net Revenue, 2015-2023
      • 13.14.3.2 Regional Market Shares, 2023
      • 13.14.3.3 R&D, 2015-2022
    • 13.14.4 Product Benchmarking
    • 13.14.5 Strategic Outlook
  • 13.15 Eli Lilly and Company
    • 13.15.1 Company Snapshot
    • 13.15.2 Company Overview
    • 13.15.3 Financial Analysis
      • 13.15.3.1 Net Revenue, 2015-2022
      • 13.15.3.2 Regional Market Shares, 2023
      • 13.15.3.3 R&D, 2015-2022
    • 13.15.4 Product Benchmarking
    • 13.15.5 Strategic Outlook
  • 13.16 Teva Pharmaceuticals Industries Ltd.
    • 13.16.1 Company Snapshot
    • 13.16.2 Company Overview
    • 13.16.3 Financial Analysis
      • 13.16.3.1 Net Revenue, 2015-2022
      • 13.16.3.2 Regional Market Shares, 2023
      • 13.16.3.3 R&D, 2015-2022
    • 13.16.4 Product Benchmarking
    • 13.16.5 Strategic Outlook
  • 13.17 Bristol-Myers Squibb
    • 13.17.1 Company Snapshot
    • 13.17.2 Company Overview
    • 13.17.3 Financial Analysis
      • 13.17.3.1 Net Revenue, 2015-2022
      • 13.17.3.2 Regional Market Shares, 2023
      • 13.17.3.3 R&D, 2015-2022
    • 13.17.4 Product Benchmarking
  • 13.18 Gerresheimer AG
    • 13.18.1 Company Snapshot
    • 13.18.2 Company Overview
    • 13.18.3 Financial Analysis
      • 13.18.3.1 Net Revenue, 2015-2023
      • 13.18.3.2 Regional Market Shares, 2023
    • 13.18.4 Product Benchmarking
    • 13.18.5 Strategic Outlook
  • 13.19 Boston Scientific Corporation
    • 13.19.1 Company Snapshot
    • 13.19.2 Company Overview
    • 13.19.3 Financial Analysis
      • 13.19.3.1 Net Revenue, 2015-2022
      • 13.19.3.2 Regional Market Shares, 2023
      • 13.19.3.3 R&D, 2015-2022
    • 13.19.4 Product Benchmarking
    • 13.19.5 Strategic Outlook

14 Conclusion and Recommendations

  • 14.1 Concluding Remarks from Visiongain
  • 14.2 Recommendations for Market Players